Cargando…
Deprescribing of Medicines in Care Homes—A Five-Year Evaluation of Primary Care Pharmacist Practices
(1) Background: This project evaluates the outcomes of a novel pharmacy-led model of deprescribing unnecessary medications for care home patients. A feasibility study was conducted in 2015 to explore exposure to inappropriate polypharmacy in patients residing in care homes over a one-year timescale....
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789793/ https://www.ncbi.nlm.nih.gov/pubmed/31382582 http://dx.doi.org/10.3390/pharmacy7030105 |
_version_ | 1783458696019312640 |
---|---|
author | Alves, Ana Green, Shaun James, Delyth H |
author_facet | Alves, Ana Green, Shaun James, Delyth H |
author_sort | Alves, Ana |
collection | PubMed |
description | (1) Background: This project evaluates the outcomes of a novel pharmacy-led model of deprescribing unnecessary medications for care home patients. A feasibility study was conducted in 2015 to explore exposure to inappropriate polypharmacy in patients residing in care homes over a one-year timescale. The aim of this study was to present the results of this ongoing service evaluation over a five-year period. (2) Methods: Data collection and risk assessment tools developed during the feasibility study were used to measure the prevalence, nature, and impact of deprescribing interventions by primary care pharmacists over a five-year period. A random sample of approximately 5% of safety interventions were screened twice yearly by the pharmacist leads as part of standard practice. (3) Results: Over a period of five years there were 23,955 interventions (mean 2.3 per patient) reported from the 10,405 patient reviews undertaken. Deprescribing accounted for 53% of total estimated financial drug savings, equating to £431,493; and 16.1% of all interventions were related to safety. (4) Conclusions: Medication reviews in care homes, undertaken by primary care pharmacists who are linked to GP practices, generate a wide range of interventions commonly involving deprescribing, which contributes significantly to the continuous optimisation of the prescribing and monitoring of medicines. |
format | Online Article Text |
id | pubmed-6789793 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-67897932019-10-16 Deprescribing of Medicines in Care Homes—A Five-Year Evaluation of Primary Care Pharmacist Practices Alves, Ana Green, Shaun James, Delyth H Pharmacy (Basel) Article (1) Background: This project evaluates the outcomes of a novel pharmacy-led model of deprescribing unnecessary medications for care home patients. A feasibility study was conducted in 2015 to explore exposure to inappropriate polypharmacy in patients residing in care homes over a one-year timescale. The aim of this study was to present the results of this ongoing service evaluation over a five-year period. (2) Methods: Data collection and risk assessment tools developed during the feasibility study were used to measure the prevalence, nature, and impact of deprescribing interventions by primary care pharmacists over a five-year period. A random sample of approximately 5% of safety interventions were screened twice yearly by the pharmacist leads as part of standard practice. (3) Results: Over a period of five years there were 23,955 interventions (mean 2.3 per patient) reported from the 10,405 patient reviews undertaken. Deprescribing accounted for 53% of total estimated financial drug savings, equating to £431,493; and 16.1% of all interventions were related to safety. (4) Conclusions: Medication reviews in care homes, undertaken by primary care pharmacists who are linked to GP practices, generate a wide range of interventions commonly involving deprescribing, which contributes significantly to the continuous optimisation of the prescribing and monitoring of medicines. MDPI 2019-08-03 /pmc/articles/PMC6789793/ /pubmed/31382582 http://dx.doi.org/10.3390/pharmacy7030105 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Alves, Ana Green, Shaun James, Delyth H Deprescribing of Medicines in Care Homes—A Five-Year Evaluation of Primary Care Pharmacist Practices |
title | Deprescribing of Medicines in Care Homes—A Five-Year Evaluation of Primary Care Pharmacist Practices |
title_full | Deprescribing of Medicines in Care Homes—A Five-Year Evaluation of Primary Care Pharmacist Practices |
title_fullStr | Deprescribing of Medicines in Care Homes—A Five-Year Evaluation of Primary Care Pharmacist Practices |
title_full_unstemmed | Deprescribing of Medicines in Care Homes—A Five-Year Evaluation of Primary Care Pharmacist Practices |
title_short | Deprescribing of Medicines in Care Homes—A Five-Year Evaluation of Primary Care Pharmacist Practices |
title_sort | deprescribing of medicines in care homes—a five-year evaluation of primary care pharmacist practices |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789793/ https://www.ncbi.nlm.nih.gov/pubmed/31382582 http://dx.doi.org/10.3390/pharmacy7030105 |
work_keys_str_mv | AT alvesana deprescribingofmedicinesincarehomesafiveyearevaluationofprimarycarepharmacistpractices AT greenshaun deprescribingofmedicinesincarehomesafiveyearevaluationofprimarycarepharmacistpractices AT jamesdelythh deprescribingofmedicinesincarehomesafiveyearevaluationofprimarycarepharmacistpractices |